我们的网站为什么显示成这样?

可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:

|本期目录/Table of Contents|

冠心病患者血浆IL-6及内脂素水平与冠状动脉病变严重程度相关性研究

《心脏杂志》[ISSN:1009-7236/CN:61-1268/R]

期数:
2016年第4期
页码:
427-430
栏目:
临床研究
出版日期:
2016-04-01

文章信息/Info

Title:
Correlation between serum IL-6, visfatin and severity of coronary artery stenosis in patients with coronary heart disease
作者:
张春艳王聪霞李永勤韩振华张 岩宋雅璠贾 珊
(西安交通大学第二附属医院心内科,陕西 西安 710004)
Author(s):
ZHANG Chun-yan WANG Cong-xia LI Yong-qin HAN Zhen-hua ZHANG Yan SONG Ya-fan JIA Shan
(Department of Cardiology, Second Affiliated Hospital of Xi’an Jiaotong University, Xi’an 710004, Shaanxi, China)
关键词:
白介素-6内脂素冠状动脉疾病动脉粥样硬化
Keywords:
interleukin-6 visfatin coronary heart disease atherosclerosis
分类号:
R541.4
DOI:
-
文献标识码:
A
摘要:
目的 分析冠心病患者血浆白介素(IL)-6和内脂素水平与冠状动脉病变严重程度的相关性。方法 选择经冠状动脉造影确诊的冠心病患者128例,分为急性冠脉综合征(ACS)组和稳定型心绞痛(SAP)组,并按病变血管支数分成3组(单支病变组、双支病变组和三支病变组),按冠状动脉狭窄程度分为3组(冠状动脉狭窄程度50%~75%组、76%~90%组及91%~100%组)。收集患者的基本临床资料,血浆IL-6及内脂素应用酶联免疫吸附法测定,应用Gensini积分评价冠状动脉病变严重程度。结果 ACS组患者IL-6及内脂素水平显著高于SAP组(P<0.05),按照不同病变血管支数分组和按照病变血管狭窄程度分组后,血浆IL-6及内脂素水平在各组间差异具有显著性(P<0.05)。相关分析显示IL-6、内脂素与Gensini积分呈正相关(分别r=0.583,r=0.724,均P<0.01)。结论 IL-6及内脂素与冠状动脉病变严重程度密切相关。
Abstract:
AIM To investigate the correlation between plasma IL-6, visfatin and severity of coronary stenosis in patients with coronary heart disease (CHD). METHODSA total of 128 patients with CHD confirmed by coronary angiography from our Department of Cardiology were divided into two groups: acute coronary syndrome (ACS) and stable angina pectoris (SAP). Patients were divided into three groups according to the number of blood vessel lesions: single lesion group, double branch lesion group and three branch lesion group and were divided into three groups on the basis of the degree of coronary artery stenosis: 50%-75% group, 76%-90% group and 91%-100% group. Clinical data of these patients were collected. ELISA kits were used to measure plasma levels of IL-6 and visfatin. Gensini score was used to evaluate the severity of coronary artery stenosis. RESULTSPlasma levels of IL-6 and visfatin in ACS group were significantly higher than those in SAP group (P<0.05). Plasma levels of IL-6 and visfatin were significantly different in patients grouped by the number of blood vessel lesions and degree of coronary artery stenosis (P<0.05). Correlation analysis showed that IL-6 and visfatin were positively associated with Gensini score (r=0.583 and 0.724, respectively, both P<0.01). CONCLUSIONPlasma IL-6 and visfatin are closely associated with the severity of coronary artery stenosis.

参考文献/References

[1]Bernberg E,Ulleryd MA,Johansson ME,et al.Social disruption stress increases IL-6 levels and accelerates atherosclerosis in ApoE-/- mice[J].Atherosclerosis,2012,221(2):359-365.
[2]Takeda N,Manabe I,Shindo T,et al.Synthetic retinoid Am80 reduces scavenger receptor expression and atherosclerosis in mice by inhibiting IL-6[J]. Arterioscler Thromb,2006,26(5):1177-1183.
[3]Petrovay F,Heltai K,Kis Z,et al.Chronic infections and histamine,CRP and IL-6 levels alter pereutaneous tl'a-18 luminal coronary angloplasty[J].Inflamm Res,2007,56(9):362-367.
[4]Gensini GG.A more meaningful scoring system for determining the severity of coronary heart disease[J].Am J Cardiol,1983,51(3):606.
[5]Dahl TB,Yndestad A,Skjelland M,et al.Increased expression of visfatin in macrophages of human unstable carotid and coronary atherosclerosis:possible role in inflammation and plaque destabilization[J].Circulation,2007,115(8):972-980.
[6]Nowell MA,Richards PJ,Fielding CA,et al.Regulation of pre-B cell colony-enhancing factor by STAT-3-dependent interleukin-6 tram-signaling:implications in the pathogenesis of rhemnatoid arthritis[J].Arthritis Rheum,2006,54(7):2084-2095.
[7]Liu SW,Qiao SB,Yuan JS,et al.Association of plasma visfatin levels with inflammation,atherosclerosis and acute coronary syndromes (ACS) in humans[J].Clin Endocrinol(Oxf),2009,71(2):202-207.
[8]王淑艳,唐与晓,孟晓梅,等.肥胖患者血清内脂素和白介素6的变化及相关因素分析[J].Chinese General Qractice,2011,14(18):2072-2073.

备注/Memo

备注/Memo:
收稿日期:2015-06-17.
基金项目:国家自然科学基金项目资助(81273828)
通讯作者:王聪霞,教授,主要从事心律失常与冠心病研究 Email:wcx622@163.com
作者简介:张春艳,住院医师,博士生 Email:yanzi_015@163.com
更新日期/Last Update: 2016-04-01